Booz Allen Hamilton Holding Corporation (BAH) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.64%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.64% | Share-based compensation / revenue. Period ending 2026-06-30. $71.00M ÷ $11.09B × 100 ≈ 0.64% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 11.09B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 71.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 1.05B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $11.09B | $71.00M | $1.05B | (m) | (m) | 0.64% | (m) | (m) |
| 2026-03-31 | (m) | $11.22B | $69.00M | $1.03B | (m) | (m) | 0.62% | (m) | (m) |
| 2025-12-31 | (m) | $11.41B | $75.00M | $1.04B | (m) | (m) | 0.66% | (m) | (m) |
| 2025-09-30 | (m) | $11.71B | $84.00M | $1.11B | (m) | (m) | 0.72% | (m) | (m) |
| 2025-06-30 | (m) | $11.96B | $93.00M | $1.37B | (m) | (m) | 0.78% | (m) | (m) |
| 2025-03-31 | (m) | $11.98B | $94.00M | $1.37B | (m) | (m) | 0.78% | (m) | (m) |
| 2024-12-31 | (m) | $11.78B | $104.53M | $1.36B | (m) | (m) | 0.89% | (m) | (m) |
| 2024-09-30 | (m) | $11.43B | $103.18M | $1.32B | (m) | (m) | 0.90% | (m) | (m) |
| 2024-06-30 | (m) | $10.95B | $97.22M | $1.03B | (m) | (m) | 0.89% | (m) | (m) |
| 2024-03-31 | (m) | $10.66B | $94.98M | $1.01B | $172.90M | (m) | 0.89% | 5.86× | Reported |
| 2023-12-31 | (m) | $10.32B | $90.56M | $706.06M | $161.63M | (m) | 0.88% | 4.37× | Reported |
| 2023-09-30 | (m) | $10.03B | $85.56M | $517.14M | $147.08M | (m) | 0.85% | 3.52× | Reported |
| 2023-06-30 | (m) | $9.66B | $84.26M | $474.07M | $130.67M | (m) | 0.87% | 3.63× | Reported |
| 2023-03-31 | (m) | $9.26B | $80.27M | $446.85M | $119.85M | (m) | 0.87% | 3.73× | Reported |
| 2022-12-31 | (m) | $9.06B | $75.59M | $638.10M | $108.18M | (m) | 0.83% | 5.90× | Reported |
| 2022-09-30 | (m) | $8.82B | $73.58M | $756.67M | $99.83M | (m) | 0.83% | 7.58× | Reported |
| 2022-06-30 | (m) | $8.62B | $71.04M | $751.12M | $95.74M | (m) | 0.82% | 7.85× | Reported |
| 2022-03-31 | (m) | $8.36B | $69.78M | $685.18M | $92.35M | (m) | 0.83% | 7.42× | Reported |
| 2021-12-31 | (m) | $8.10B | $64.06M | $707.84M | $89.57M | (m) | 0.79% | 7.90× | Reported |
| 2021-09-30 | (m) | $7.98B | $62.64M | $714.89M | $86.77M | (m) | 0.79% | 8.24× | Reported |
| 2021-06-30 | (m) | $7.89B | $61.45M | $703.74M | $82.31M | (m) | 0.78% | 8.55× | Reported |
| 2021-03-31 | (m) | $7.86B | $59.84M | $754.37M | $81.27M | (m) | 0.76% | 9.28× | Reported |
| 2020-12-31 | (m) | $7.85B | $57.47M | $732.44M | $82.58M | (m) | 0.73% | 8.87× | Reported |
| 2020-09-30 | (m) | $7.79B | $53.11M | $717.23M | $85.93M | (m) | 0.68% | 8.35× | Reported |
| 2020-06-30 | (m) | $7.60B | $47.68M | $682.04M | $92.01M | (m) | 0.63% | 7.41× | Reported |
| 2020-03-31 | (m) | $7.46B | $43.29M | $669.20M | $96.96M | (m) | 0.58% | 6.90× | Reported |
| 2019-12-31 | (m) | $7.27B | $34.84M | $655.23M | $97.44M | (m) | 0.48% | 6.72× | Reported |
| 2019-09-30 | (m) | $7.09B | $33.82M | $648.11M | $95.25M | (m) | 0.48% | 6.80× | Reported |
| 2019-06-30 | (m) | $6.88B | $31.60M | $619.83M | $91.63M | (m) | 0.46% | 6.76× | Reported |
| 2019-03-31 | (m) | $6.70B | $31.27M | $602.39M | $89.52M | (m) | 0.47% | 6.73× | Reported |
| 2018-12-31 | (m) | (m) | $29.75M | $599.35M | $89.32M | (m) | (m) | 6.71× | Reported |
| 2018-09-30 | (m) | (m) | $24.99M | $565.89M | $87.89M | (m) | (m) | 6.44× | Reported |
| 2018-06-30 | (m) | (m) | $24.18M | $555.03M | $86.60M | (m) | (m) | 6.41× | Reported |
| 2018-03-31 | (m) | (m) | $23.32M | $520.09M | $82.27M | (m) | (m) | 6.32× | Reported |
| 2017-12-31 | (m) | (m) | $22.01M | $513.20M | $75.85M | (m) | (m) | 6.77× | Reported |
| 2017-09-30 | (m) | (m) | $22.26M | $503.24M | $69.42M | (m) | (m) | 7.25× | Reported |
| 2017-06-30 | (m) | (m) | $20.61M | $494.41M | $63.22M | (m) | (m) | 7.82× | Reported |
| 2017-03-31 | (m) | (m) | $21.25M | $484.25M | $62.30M | (m) | (m) | 7.77× | Reported |
| 2016-12-31 | (m) | (m) | $23.22M | $459.59M | $64.64M | (m) | (m) | 7.11× | Reported |
| 2016-09-30 | (m) | (m) | $24.05M | $456.59M | $68.22M | (m) | (m) | 6.69× | Reported |
| 2016-06-30 | (m) | (m) | $24.62M | $447.74M | $71.15M | (m) | (m) | 6.29× | Reported |
| 2016-03-31 | (m) | (m) | $24.99M | $444.58M | $70.81M | (m) | (m) | 6.28× | Reported |
| 2015-12-31 | (m) | (m) | $24.02M | $432.64M | $70.22M | (m) | (m) | 6.16× | Reported |
| 2015-09-30 | (m) | (m) | $24.80M | $432.78M | $70.33M | (m) | (m) | 6.15× | Reported |
| 2015-06-30 | (m) | (m) | $26.37M | $445.94M | $70.46M | (m) | (m) | 6.33× | Reported |
| 2015-03-31 | (m) | (m) | $26.16M | $458.82M | $71.83M | (m) | (m) | 6.39× | Reported |
| 2014-12-31 | (m) | (m) | $25.90M | $455.50M | $72.81M | (m) | (m) | 6.26× | Reported |
| 2014-09-30 | (m) | (m) | $23.61M | $447.28M | $73.82M | (m) | (m) | 6.06× | Reported |
| 2014-06-30 | (m) | (m) | $20.98M | $460.96M | $76.18M | (m) | (m) | 6.05× | Reported |
| 2014-03-31 | (m) | (m) | $20.07M | $460.61M | $78.03M | (m) | (m) | 5.90× | Reported |
| 2013-12-31 | (m) | (m) | $19.10M | $484.25M | $79.26M | (m) | (m) | 6.11× | Reported |
| 2013-09-30 | (m) | (m) | $19.82M | $503.81M | $82.11M | (m) | (m) | 6.14× | Reported |
| 2013-06-30 | (m) | (m) | $23.23M | $470.17M | $79.75M | (m) | (m) | 5.90× | Reported |
| 2013-03-31 | (m) | (m) | $24.84M | $446.23M | $70.28M | (m) | (m) | 6.35× | Reported |
| 2012-12-31 | (m) | (m) | $26.68M | $430.82M | $62.34M | (m) | (m) | 6.91× | Reported |
| 2012-09-30 | (m) | (m) | $27.18M | $412.41M | $52.65M | (m) | (m) | 7.83× | Reported |
| 2012-06-30 | (m) | (m) | $27.35M | $404.05M | $47.03M | (m) | (m) | 8.59× | Reported |
| 2012-03-31 | (m) | (m) | $31.26M | $387.43M | $48.08M | (m) | (m) | 8.06× | Reported |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | $48.68M | $319.44M | $131.89M | (m) | (m) | 2.42× | Reported |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | $71.90M | $199.55M | $150.73M | (m) | (m) | 1.32× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genpact LTD (G) | $5.608B | 7.94 | |
| FTI CONSULTING, INC (FCN) | United States | $3.602B | 16.33 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| Astrana Health, Inc. (ASTH) | United States | $1.921B | 63.77 |
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |